RTC
IDYA icon

Riverview Trust Company’s IDEAYA Biosciences IDYA Stock Holding History

Riverview Trust Company’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-19
Closed -$488 – 713
2024
Q4 		$488 Buy
+19
New +$538 ﹤0.01% 797

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Riverview Trust Company's IDYA Position: Q1 2025 in Review

Riverview Trust Company sold out of IDEAYA Biosciences (IDYA) in Q1 2025, closing a stake of 19 shares — an estimated $488 sold.

Riverview Trust Company first reported a position in IDYA in Q4 2024 and held it in 1 quarter. The position peaked at $488 in Q4 2024. 207 funds tracked by Wall St. Rank hold IDYA as of Q1 2025.

  • Riverview Trust Company reported no remaining IDEAYA Biosciences position as of Q1 2025 after selling out during the quarter.
  • Riverview Trust Company sold 19 IDEAYA Biosciences shares in Q1 2025, an estimated $488.
  • Riverview Trust Company first reported a position in IDEAYA Biosciences in Q4 2024 and held it in 1 quarter.
  • Riverview Trust Company's IDEAYA Biosciences position peaked at $488 in Q4 2024.
  • 207 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q1 2025.

Based on Riverview Trust Company's 13F filing for Q1 2025, filed 11 Apr 2025.